This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting set for Q2 and half-year results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 2.2 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board will meet on November 5, 2026 at 3:00 PM IST to approve the unaudited financial results for the quarter and half-year ended September 30, 2026. Insider trading is closed from October 1 until 48 hours after the results are declared. No financial figures were provided.
No results are yet available. Shareholders should wait for the November 5 declaration and assess the reported profit, cash flow and outlook.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹2.78 Cr | ₹8.69 Cr | −68.0% |
| Operating profit | −₹0.36 Cr | −₹0.01 Cr | loss widened |
| Profit after tax | ₹0.27 Cr | ₹0.12 Cr | +135.7% |
| EBITDA margin | -11.5% | 4.6% | −16.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.